Roy Blum

2.2k citations

30 papers · 1.6k indexed · h-index 20

Impact in

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
- Muscle Physiology and Disorders
- RNA Research and Splicing
- Cancer-related gene regulation

Papers in ⓘ

Cancer Research 7
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 3
Molecular Biology 22
- Genomics and Chromatin Dynamics 7
- RNA Research and Splicing 7
- Epigenetics and DNA Methylation 6
- Melanoma and MAPK Pathways 5
- RNA modifications and cancer 5
- Protein Kinase Regulation and GTPase Signaling 4

Co-authors: Yoel Kloog (9 shared papers)Brian David Dynlacht (4 shared papers)Gideon Rechavi (5 shared papers)Jasmine Jacob‐Hirsch (4 shared papers)Christopher Bowman (3 shared papers)Ninette Amariglio (2 shared papers)Vasupradha Vethantham (2 shared papers)Jemmie Cheng (2 shared papers)
Journals: PLoS ONE (3 papers)Proceedings of the National Academy of Sciences (2 papers)Nature Structural & Molecular Biology (2 papers)Molecular Cell (2 papers)Genes & Development (2 papers)
Partner nations: United States Israel South Africa

In The Last Decade

Roy Blum

30 papers receiving 1.6k citations

Peers

Countries citing papers authored by Roy Blum

Since Specialization

Citations

This map shows the geographic impact of Roy Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Blum more than expected).

Fields of papers citing papers by Roy Blum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Blum. The network helps show where Roy Blum may publish in the future.

Co-authors

The 25 scholars most cited alongside Roy Blum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roy Blum Line = papers co-authored together Roy Blum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Genome-wide remodeling of the epigenetic landscape during myogenic differentiation Proceedings of the National Academy of Sciences ·Patrik Asp, Roy Blum, Vasupradha Vethantham, Fabio Parisi, Mariann Micsinai, Jemmie Cheng, Christopher Bowman, Yuval Kluger, Brian David Dynlacht	2011	232
2	A Role for H3K4 Monomethylation in Gene Repression and Partitioning of Chromatin Readers Molecular Cell ·Jemmie Cheng, Roy Blum, Christopher Bowman, Deqing Hu, Ali Shilatifard, Steven S. Shen, Brian David Dynlacht	2014	161
3	Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. PubMed ·Roy Blum, Jasmine Jacob‐Hirsch, Ninette Amariglio, Gideon Rechavi, Yoel Kloog	2005	156
4	Ras Inhibition in Glioblastoma Down-regulates Hypoxia-Inducible Factor-1α, Causing Glycolysis Shutdown and Cell Death Cancer Research ·Roy Blum, Jasmine Jacob‐Hirsch, Ninette Amariglio, Gideon Rechavi, Yoel Kloog	2005	147
5	Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1 Genes & Development ·Roy Blum, Vasupradha Vethantham, Christopher Bowman, Michael A. Rudnicki, Brian David Dynlacht	2012	130
6	Metabolism addiction in pancreatic cancer Cell Death and Disease ·Roy Blum, Yoel Kloog	2014	113
7	Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer Lung Cancer ·William K. Evans, Robert Makuch, Gerald H. Clamon, Ronald Feld, Roy S. Weiner, Edgar M. Moran, Roy Blum, Frances A. Shepherd, Khursheed N. Jeejeebhoy, William D. DeWys	1986	103
8	Molecular Signatures of Prostate Stem Cells Reveal Novel Signaling Pathways and Provide Insights into Prostate Cancer PLoS ONE ·Roy Blum, Rashmi Gupta, Patricia E. Burger, Christopher S. Ontiveros, Sarah N. Salm, Xiaozhong Xiong, Alexander Kamb, Holger Wesche, Lisa A. Marshall, Gene Cutler, Xiangyun Wang, Jiří Zavadil, David Moscatelli, E. Lynette Wilson	2009	54
9	Tailoring Ras-pathway—Inhibitor combinations for cancer therapy Drug Resistance Updates ·Roy Blum, Yoel Kloog	2005	51
10	Inhibitors of Chronically Active Ras: Potential for Treatment of Human Malignancies Recent Patents on Anti-Cancer Drug Discovery ·Yoel Kloog, Roy Blum, Adrienne D. Cox	2008	51
11	The role of MyoD1 and histone modifications in the activation of muscle enhancers Epigenetics ·Roy Blum, Brian David Dynlacht	2013	49
12	Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome Nature Structural & Molecular Biology ·Teddy Jégu, Roy Blum, Jesse C. Cochrane, Lin Yang, Chen‐Yu Wang, Maud-Emmanuelle Gilles, David Colognori, Attila Szántó, Sharon K. Marr, Robert E. Kingston, Jeannie T. Lee	2019	46
13	Suppression of survivin expression in glioblastoma cells by the Ras inhibitor farnesylthiosalicylic acid promotes caspase-dependent apoptosis Molecular Cancer Therapeutics ·Roy Blum, Jasmine Jacob‐Hirsch, Gideon Rechavi, Yoel Kloog	2006	43
14	Gene Expression Signature of Human Cancer Cell Lines Treated with the Ras Inhibitor Salirasib ( S -Farnesylthiosalicylic Acid) Cancer Research ·Roy Blum, Ran Elkon, Shira Yaari, Adi Zundelevich, Jasmine Jacob‐Hirsch, Gideon Rechavi, Ron Shamir, Yoel Kloog	2007	40
15	Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells Biochemical Pharmacology ·Shlomit Erlich, Pazit Tal‐Or, Ronit Liebling, Roy Blum, Devarajan Karunagaran, Yoel Kloog, Ronit Pinkas‐Kramarski	2006	39
16	Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model Journal of Biological Chemistry ·Courtney L. Jones, Teena Bhatla, Roy Blum, Jinhua Wang, Steven W. Paugh, Xin Wen, Wallace Bourgeois, Danielle S. Bitterman, Elizabeth A. Raetz, D. Morrison, David T. Teachey, William E. Evans, Michael J. Garabedian, William L. Carroll	2014	38
17	Motif-driven interactions between RNA and PRC2 are rheostats that regulate transcription elongation Nature Structural & Molecular Biology ·Michael A. Rosenberg, Roy Blum, Barry Kesner, Eric Aeby, Jean‐Michel Garant, Attila Szántó, Jeannie T. Lee	2021	29
18	Tsix–Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function Proceedings of the National Academy of Sciences ·Lieselot L. G. Carrette, Roy Blum, Weiyuan Ma, Raymond J. Kelleher, Jeannie T. Lee	2018	28
19	E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell‐cycle arrest in response to ras inhibition International Journal of Cancer ·Roy Blum, Itay Nakdimon, Liat Goldberg, Ran Elkon, Ron Shamir, Gideon Rechavi, Yoel Kloog	2006	21
20	Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3′ UTRs to Regulate mRNA Expression Cell Systems ·Michael A. Rosenberg, Roy Blum, Barry Kesner, Verena Maier, Attila Szántó, Jeannie T. Lee	2017	20

About Roy Blum

Roy Blum is a scholar working on Cancer Research, Molecular Biology, Oncology, Hematology and Urology, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (7 papers), RNA Research and Splicing (7 papers), Epigenetics and DNA Methylation (6 papers), Melanoma and MAPK Pathways (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (458 citations), Molecular Biology (1.3k citations), Oncology (284 citations), Genetics (79 citations) and Physiology (159 citations). Roy Blum has collaborated with scholars based in United States, Israel and South Africa. Frequent co-authors include Yoel Kloog, Brian David Dynlacht, Gideon Rechavi, Jasmine Jacob‐Hirsch, Christopher Bowman, Ninette Amariglio, Vasupradha Vethantham, Jemmie Cheng, Patrik Asp and Michael A. Rudnicki. Their work appears in journals such as PLoS ONE, Proceedings of the National Academy of Sciences, Nature Structural & Molecular Biology, Molecular Cell and Genes & Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact